• Capturing Pre-Commercial-$tage Value

    Welcome to Life Science Deal Flow. Our aim here is to hold my mouse to the fire by documenting the winners (and losers) of my life science trades and strategies. The focus is on a unique opportunities presented by pre-commercial stage life science entities. Don't forget to visit and subscribe to my other site, a FREE Venture Capital and competitive intelligence dBase, OnBioVC.
  • SEARCH the Life Science Deal Flow ARCHIVE

  • business strategy life science

Some people read the Old Testament, others may read the New Testament, the Koran, the Bhagavad Gita, or the Guru Granth Sahib, my bible has become…Valuation in Life Sciences: A Practical Guide by Dr. Boris Bogdan and Ralph Villiger. This work has emerged as my one unambiguous go-to text when it comes to evaluation and [...]

The blogosphere is an amazing place, enabling the cultivation of rich relationships that may otherwise never come to pass. One such contact I have been lucky enough to cultivate is with Yali Friedman, Ph.D. the founder of thinkBiotech and author of Building Biotechnology and the BioTechBlog. Yali’s newest work released today is Best Practices in [...]

For the first time in years, say since undergrad, I sat down and consumed an entire book, cover-to-cover in a single sitting. It was Valley Boy: The Education of Tom Perkins that sucked me in on a snowy Sunday. Tom Perkins helped to pioneer the innovation center that is Silicon Valley, first at Hewlett Packard [...]

Finishing off Michael West’s (founder of Geron NASDAQ: GERN and Advanced Cell Technology OTCBB: ACTC.OB) The Immortal Cell (TIC) left me with a lingering thought…my geophysical and other biases aside…Colorado truly is an amazing place, and without a doubt has been (since Keith Porter’s arrival) and continues to remain at the forefront of innovation from [...]

I recently completed Science Business: The Promise, the Reality, and the Future of Biotech. Time spent reading was a rewarding allocation sans for Part I where author Gary Pisano, Professor of Business Administration at Harvard Business School, focuses upon a survey of the technologies, tools and theories that the biotechnology industry is built upon. Don’t [...]

  

to top of page...


 
  • The Latest LSDF Activity

    May 2012
    M T W T F S S
    « Oct    
     123456
    78910111213
    14151617181920
    21222324252627
    28293031  
  • Search the LSDF Archive

  • Your Advert Can Go Here!

    Find out how, email: arubenstein@rnaventures.com